ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 234 • 2014 ACR/ARHP Annual Meeting

    The Decrease in Prescription of Anti-Osteoporotic Drugs Has No Impact on Hip Fracture Incidence

    Karine Briot1, Milka Maravic2 and Christian Roux3, 1Cochin Hospital, Paris Descartes University, Paris, France, 2Hopital Leopold Bellan, Paris, France, 3Paris Descartes University, Cochin Hospital, Paris, France

    Background/Purpose Controversies exist about the change in hip fracture incidence among countries. In France, we previously showed that the incidence of hip fractures decreased in…
  • Abstract Number: 233 • 2014 ACR/ARHP Annual Meeting

    Significance of Serum Marker Levels of Wnt/ß-Catenin Signaling Pathway in Patients with Systemic Autoimmune Diseases Under Glucocorticoid Therapy; A Prospective Study

    Mai Kawazoe, Kotaro Shikano, Kaichi Kaneko, Shotaro Masuoka, Hiroshi Sato, Emiko Shindo, Natsuki Fujio, Sei Muraoka, Makoto Kaburaki, Nahoko Tanaka, Tatsuhiro Yamamoto, Kenji Takagi, Natsuko Kusunoki, Tomoko Hasunuma and Shinichi Kawai, Division of Rheumatology, Department of Internal Medicine, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan

    Background/Purpose:  Glucocorticoids are widely used to treat a variety of diseases, including systemic autoimmune diseases. Although glucocorticoids improve the outcome for patients with these diseases,…
  • Abstract Number: 232 • 2014 ACR/ARHP Annual Meeting

    Significance of Serum Srankl and Osteoprotegerin Concentration in Patients with Rheumatoid Arthritis

    Kotaro Shikano, Kaichi Kaneko, Mai Kawazoe, Shotaro Masuoka, Hiroshi Sato, Emiko Shindo, Natsuki Fujio, Makoto Kaburaki, Sei Muraoka, Nahoko Tanaka, Tatsuhiro Yamamoto, Kenji Takagi, Natsuko Kusunoki, Tomoko Hasunuma and Shinichi Kawai, Division of Rheumatology, Department of Internal Medicine, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan

    Background/Purpose Rheumatoid arthritis (RA) is known as a cause of secondary osteoporosis. The previous studies reported that receptor activator for nuclear factor κB ligand (RANKL)…
  • Abstract Number: 231 • 2014 ACR/ARHP Annual Meeting

    Factors Predicting Fracture in the over-75s: An Observational Case-Control Study

    Christopher Varley1, James Fowler2, Alexander Oldroyd1 and Marwan Bukhari3, 1Lancaster Medical School, Lancaster University, Lancaster, United Kingdom, 2Faculty of Health and Medicine, Lancaster Univeristy, Lancaster, United Kingdom, 3Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

    Background/Purpose In the over 75s the diagnosis of osteoporosis may be assumed following a fracture, making the need for a dual energy absorptiometry scan (DEXA)…
  • Abstract Number: 230 • 2014 ACR/ARHP Annual Meeting

    Risk Factors That Predict Poor Bone Health in Those Aged over 75 Years – a Cross Sectional Study

    James Fowler1,2, Christopher Varley3, Alexander Oldroyd3 and Marwan Bukhari3, 1Faculty of Health and Medicine, Lancaster Univeristy, Lancaster, United Kingdom, 2University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom, 3Lancaster Medical School, Lancaster University, Lancaster, United Kingdom

    Background/Purpose .No studies have been conducted into the over 75 population specifically to assess the risk factors that predict BMD loss. The Framingham Osteoporosis Study…
  • Abstract Number: 229 • 2014 ACR/ARHP Annual Meeting

    Correlates of Heel Bone Mass in Young Adults: The Role of Cholesterol over 20 Years from Childhood to Early Adulthood

    Benny Samuel Eathakkattu Antony1, Changhai Ding2, Alison Venn3, Terry Dwyer4 and Graeme Jones2, 1Musculoskeletal, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia, 2Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, 3Epidemiology, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, 4Director, Murdoch Children's Research Institute, Melbourne, Australia

    Background/Purpose The association between lipids and bone mass in adult life is controversial and there is limited evidence in childhood. The aim of this study…
  • Abstract Number: 228 • 2014 ACR/ARHP Annual Meeting

    Is Adult Hypophosphatasia a Cardiovascular Risk Factor?

    Leyre Riancho-Zarrabeitia1, Maria T. García-Unzueta2, Alfonso Corrales3, Juan Gómez-Gerique2 and José A. Riancho4, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 2Biochemistry, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 3Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 4Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. University of Cantabria, Santander, Spain

    Background/Purpose Mild forms of adult hypophosphatasia may have subtle manifestations, and may go unrecognized. The aim of this study was to get a better knowledge of its clinical spectrum. Methods We performed a computerized search of low total alkaline phosphatase among laboratory records.  The diagnosis of hypophosphatasia was confirmed by measuring serum pyridoxal phosphate (PLP) and bone alkaline phosphatase. Carotid ultrasonography was performed in patients and controls with a MyLab 70…
  • Abstract Number: 227 • 2014 ACR/ARHP Annual Meeting

    Increasing Fat-Mass May Reverse Bone Loss As Detected By DXA Scan

    William Hedges1 and Marwan Bukhari2,3, 1Foundation Programme, Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom, 2Lancaster Medical School, Lancaster University, Lancaster, United Kingdom, 3Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

    Background/Purpose: Low body mass index (BMI) is a known risk factor for loss of bone mineral density (BMD). It is a part of the FRAX…
  • Abstract Number: 226 • 2014 ACR/ARHP Annual Meeting

    Improved Prediction of Hip Fracture Using the Health Assessment Questionnaire-Disability Index and FRAX® in Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Study

    Takefumi Furuya1, Eisuke Inoue2, Kensuke Ochi1, Osamu Ishida3, Atsuo Taniguchi4, Shigeki Momohara4 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 3Orthopedics, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 4Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose: The World Health Organization Fracture Risk Assessment Tool (FRAX®) algorithm can be used to estimate 10-year probabilities of hip and major osteoporotic fractures. Previously,…
  • Abstract Number: 225 • 2014 ACR/ARHP Annual Meeting

    Association Between Lean Mass and Hip Bone Mineral Density

    Charlotte Beaudart1, Jean-Yves Reginster2, Justine Slomian3, Fanny Buckinx4 and Olivier Bruyere5, 1Avenue De L'Hopital 3, University of Liège, Liège, Belgium, 2Bone Cartilage Unit, University of Liège, Liège, Belgium, 3Support Unit in Epidemiology and Biostatistics, University of Liège, Liège, Belgium, 4Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, 5Public Health/Epidemiology, University of Liège, Liège, Belgium

    Background/Purpose: Fat mass and lean mass (LM) represent 95% of body weight. However, the role of each component on bone mineral density (BMD) is not…
  • Abstract Number: 224 • 2014 ACR/ARHP Annual Meeting

    Is the Protective Effect of Obesity Against Hip Fracture Due to Changes of Proximal Femur Shape?

    Alexander Oldroyd1 and Marwan Bukhari1,2, 1Lancaster Medical School, Lancaster University, Lancaster, United Kingdom, 2Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

    Background/Purpose: The association between increasing body mass index (BMI), increasing bone mineral density (BMD) and lower hip fracture risk has been demonstrated by previous research. Studies…
  • Abstract Number: 223 • 2014 ACR/ARHP Annual Meeting

    Risk Factors for Clinical Vertebral Fractures in Japanese Men and Women with Rheumatoid Arthritis: Results from a Large Prospective Observational Cohort Study

    Osamu Ishida1, Takefumi Furuya2, Eisuke Inoue3, Kensuke Ochi2, Katsunori Ikari2, Atsuo Taniguchi4, Hisashi Yamanaka2 and Shigeki Momohara4, 1Orthopedics, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 3Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 4Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose: Patients with rheumatoid arthritis (RA) are at high risk of developing vertebral fractures. Previously, utilizing data from our Institute of Rheumatology Rheumatoid Arthritis (IORRA)…
  • Abstract Number: 220 • 2014 ACR/ARHP Annual Meeting

    Lower Extremity Presarcopenia Is Associated with the Severity of Knee Pain

    Yun-Hong Cheon1, Wan-Hee Yoo2, Young Sun Suh3, Hyun-Ok Kim3, Ki-Soo Park4, Sang-Il Lee3 and Hye-Ji Jeon4, 1Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Jeonju, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Chonbuk National University School of Medicine, Jeonju, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea, 4Department of Preventive Medicine, Gyeongsang National University School of Medicine, Jinju, South Korea

    Background/Purpose Presarcopenia, which is defined as skeletal muscle mass loss, and knee pain have been gained attention with ageing. Little is known about the association…
  • Abstract Number: 221 • 2014 ACR/ARHP Annual Meeting

    An Analysis of Age-Related Loss of Skeletal Muscle Mass and Its Significance on Osteoarthritis in a Korean Population

    Hyunje Kim1, Minjung Kim1, Choong Ki Lee2 and Young Hoon Hong3, 1Internal medicine, School of medicine, Yeungnam University, Daegu, South Korea, 2Internal medicine, school of medicine, Yeungnam University, Daegu, South Korea, 3Department of Internal medicine, School of Medicine,, Yeungnam University, Daegu, South Korea

    Background/Purpose This study was conducted in order to analyze the effects of sarcopenia and sarcopenic obesity on age-related OA of the knee in a Korean…
  • Abstract Number: 222 • 2014 ACR/ARHP Annual Meeting

    OA Phenotypes Rather Than Disease Stage Drive Structural Progression – Identification of Structural Progressors from 2 Phase III Randomized Clinical studies with Symptomatic Knee OA

    Morten Asser Karsdal1, Anne C. Bay-Jensen2, Asger Bihlet3, Peter Alexandersen4, Inger Byrjalsen3, Bente J. Riis3 and Claus Christiansen3, 1Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 2Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 3Nordic Bioscience, Herlev, Denmark, 4Center for Clinical and Basic Research, Vejle, Denmark

    Background/Purpose: Osteoarthritis (OA) is a heterogeneous disorder, with several possible drivers of disease progression. Up to 50% of OA patients do not structurally progress, emphasizing…
  • « Previous Page
  • 1
  • …
  • 2034
  • 2035
  • 2036
  • 2037
  • 2038
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology